vaccine boosters

COVID-19

COVID-19 vaccine boosters could mean billions for drug makers

Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus. How much the manufacturers stand to gain depends on how big the rollout proves to be. U.S. health officials late on Thursday endorsed booster shots of the

COVID-19

US panel backs COVID-19 boosters only for seniors, high-risk

Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra vaccine dose only for those who are 65 or older or run a high risk of severe disease. The twin votes represented a heavy blow

Scroll to Top